Even when given the same drug, some patients respond well while others show little or no response. This is particularly true ...

Matthew Gubens, MD, MS, explains how PD-L1 expression, disease burden, and co-mutations guide first-line immunotherapy selection in metastatic non–small cell lung cancer. Selecting first-line ...

A newly approved immunotherapy was effective for some forms of rectal cancer without the need for additional treatments.

For decades, the standard of care for patients with resected stage II and III colon cancer has centred on surgery with consideration of postoperative adjuvant systemic therapy to reduce risk of ...

Christopher Burston’s bowel cancer appeared to disappear after just nine weeks of immunotherapy, yet he still underwent ...

The GSK cancer immunotherapy Jemperli is now approved for treating advanced cases of rectal cancer harboring a particular ...

Researchers discovered that recurring arthritis triggered by cancer immunotherapy may be driven by immune cells that remember ...

Doctors in Tampa are experimenting with a way to treat breast cancer without chemotherapy.

The FDA approved dostarlimab for patients with MSI-H/dMMR rectal cancer. In a study of 154 people, 68% had a complete ...

Two new studies led by researchers at the UCLA Health Jonsson Comprehensive Cancer Center provide new insight into how the ...

The ENERGIZE trial explores nivolumab plus chemotherapy and IDO1 inhibition with linrodostat in MIBC, with implications for ...

Key Updates in Gastric and Esophageal Cancer Management / cancer, cancer care, Cancer research, cancer treatment, chemotherapy, clinical ...